Baker Avenue Asset Management, LP Abiomed Inc Transaction History

Baker Avenue Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $2.16 Million - $2.68 Million	-8,455 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$130.51 - $196.01 $9,396 - $14,112	-72 Reduced 0.84%	8,455 $1.23 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $1.36 Million - $1.91 Million	8,527 New	8,527 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $1.16 Million - $1.32 Million	-4,627 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $1.28 Million - $1.68 Million	4,627 New	4,627 $1.32 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.